These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24445060)

  • 1. Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients.
    Tavira B; Gómez J; Díaz-Corte C; Llobet L; Ruiz-Pesini E; Ortega F; Coto E
    Gene; 2014 Mar; 538(1):195-8. PubMed ID: 24445060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients.
    Tavira B; Coto E; Díaz-Corte C; Ortega F; Arias M; Torres A; Díaz JM; Selgas R; López-Larrea C; Campistol JM; Ruiz-Ortega M; Alvarez V;
    Clin Transplant; 2011; 25(3):E284-91. PubMed ID: 21355884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
    Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T
    Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus.
    Tavira B; Coto E; Torres A; Díaz-Corte C; Díaz-Molina B; Ortega F; Arias M; Díaz JM; Selgas R; López-Larrea C; Ruiz-Ortega M; Ortiz A; González E; Campistol JM; Alvarez V;
    Mol Genet Metab; 2012 Mar; 105(3):525-7. PubMed ID: 22264780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
    Nishimura K; Kishikawa H; Kato T; Kobayashi Y; Fujii N; Takahara S; Ichikawa Y
    Transpl Int; 2009 Jul; 22(7):694-701. PubMed ID: 19254242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus.
    Kurzawski M; Dziewanowski K; Łapczuk J; Wajda A; Droździk M
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1587-94. PubMed ID: 22569928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
    Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I
    Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset diabetes after transplantation: drug-related risk factors.
    Santos L; Rodrigo E; Piñera C; Quintella E; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; de Francisco A; Arias M
    Transplant Proc; 2012 Nov; 44(9):2585-7. PubMed ID: 23146462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials.
    First MR; Dhadda S; Croy R; Holman J; Fitzsimmons WE
    Transplantation; 2013 Jul; 96(1):58-64. PubMed ID: 23619735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
    Reddy YN; Abraham G; Sundaram V; Reddy PP; Mathew M; Nagarajan P; Mehra N; Ramachandran A; Ali AA; Reddy YN
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1113-20. PubMed ID: 26586047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriers.
    Fougeray S; Loriot MA; Nicaud V; Legendre C; Thervet E; Pallet N
    Transplant Proc; 2011 Nov; 43(9):3418-22. PubMed ID: 22099811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of the transcription factor NFATc4 and development of new-onset diabetes after transplantation in Hispanic kidney transplant recipients.
    Chen Y; Sampaio MS; Yang JW; Min D; Hutchinson IV
    Transplantation; 2012 Feb; 93(3):325-30. PubMed ID: 22234350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
    Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.
    Chen QJ; Li J; Zuo SR; Zhang YP; Jia SJ; Yuan H; Liu SK; Cheng K; Ming YZ; Zuo XC; Luo AJ; Xie WZ; Cai JJ; Yang M; Wang JL
    Ren Fail; 2015 May; 37(4):601-6. PubMed ID: 25644968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.
    Ghisdal L; Bouchta NB; Broeders N; Crenier L; Hoang AD; Abramowicz D; Wissing KM
    Transpl Int; 2008 Feb; 21(2):146-51. PubMed ID: 17971033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
    Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
    Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesemia in renal transplant recipients: relation with immunosuppression and posttransplant diabetes.
    Osorio JM; Bravo J; Pérez A; Ferreyra C; Osuna A
    Transplant Proc; 2010 Oct; 42(8):2910-3. PubMed ID: 20970568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of new onset of diabetes after transplantation in stable renal recipients.
    Shehab-Eldin W; Shoker A
    Nephron Clin Pract; 2008; 110(1):c1-9. PubMed ID: 18654089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial haplogroups associated with end-stage heart failure and coronary allograft vasculopathy in heart transplant patients.
    Gallardo ME; García-Pavía P; Chamorro R; Vázquez ME; Gómez-Bueno M; Millán I; Almoguera B; Domingo V; Segovia J; Vilches C; Alonso-Pulpón L; Garesse R; Bornstein B
    Eur Heart J; 2012 Feb; 33(3):346-53. PubMed ID: 21821846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.